Hurry to swim wide and narrow alleys
Release time:
2020-07-22
hurried through Kuanzhai Alley
. He has been to Chengdu twice, including the famous Chunxi Road, Du Fu Thatched Cottage, Wuhou Temple, Dujiangyan and Qingcheng Mountain. As the largest city in Southwest China, the development and changes of Chengdu in recent years are also changing with each passing day. However, for me, the prosperity of modern city is not attractive. It is the wide and narrow alleys of Chengdu's famous historical and cultural streets. I am full of interest.
I finally had a chance recently. After a few hours of free time during the transfer process, I took the bus to the subway. It took a lot of trouble and walked to Kuanzhai Alley. Although it is not as large as the ancient city of Lijiang, the ancient city of Dukezong, and the ancient city of Phoenix, it is indeed unique to be able to enjoy such an antique place in the surrounding cities with an inch of gold and high-rise buildings. It's like after listening to the passionate and impetuous rock jazz, turning around and placing it in the artistic conception of the trickle-like chanting of the song "Chengdu.
Kuanzhai Alley is actually composed of parallel arrangement of wide alleys, narrow alleys and well alleys. There are also narrow paths or courtyards between the alleys. The alleys are almost all antique courtyard houses of Qingdai bricks and tiles. This is also a relatively large-scale Qingchao ancient street left over from Chengdu. Together with Daci Temple and Wenshu Temple, it is also called the protected block of Chengdu's three famous historical and cultural city. It is understood that in Kangxi 57 , after pacifying the Junggar Rebellion, the ruler chose more than 1,000 soldiers to garrison Chengdu and built a full city on the basis of the small city of that year. In the early years of the Republic of China, the managers at that time changed the "hutong" to "alley". It was not until the 1970 s and 1980 s that Kuanzhai Alley was included in the "Chengdu Historical and Cultural City Protection Plan", and this block has gradually become a commercial pedestrian street with Chinese characteristics. In recent years, with the development of tourism, Kuanzhai Alley has also begun to become the new ten sights of Chengdu, the famous historical and cultural streets of Sichuan, and the ten most beautiful streets.
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31